We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma (HBV-HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00720668
Recruitment Status : Unknown
Verified February 2009 by Sun Yat-sen University.
Recruitment status was:  Recruiting
First Posted : July 23, 2008
Last Update Posted : February 9, 2009
Sponsor:
Information provided by:
Sun Yat-sen University